Rating Roundup: Jaguar Animal Cmn (JAGX)

Remigio Civitarese
Novembre 15, 2017

Jaguar Health, Inc. (NASDAQ:JAGX)'s market cap, the total dollar value of all of their outstanding shares, is 14.63m. While the stock price moved along with the volume change, shares are touching $17.57. Its minimum price target estimates has been figured out at $2 while the maximum price target forecast is established at $10.

Wall Street analysts are predicting that Jaguar Animal Cmn (NASDAQ:JAGX) will report earnings per share of $-0.13 in their quarterly report.

Rodman & Renshaw "Initiates Coverage On" Jaguar Animal Cmn (NASDAQ:JAGX) in a research note issued to investors on 7/11/17 to Buy with price target of $2.

On the other hand Jaguar Animal Cmn (NASDAQ:JAGX) has Relative Strength Index (RSI 14) of 48.5 along with Average True Range (ATR 14) of 0.03. For the current quarter Jaguar Animal Cmn (NASDAQ:JAGX) has high EPS estimates of $-0.13 in contradiction of low EPS estimates of $-0.13. The company's 50-day moving average price is $0.69 and its 200-day moving average price is $1.12. Average estimation for the current quarter has been provided by 1 analysts. For the current year the company's revenue estimates are $5.59 Million compared to low analyst estimates of $5.59 Million and high estimates of $5.59 Million according to the prediction of 1 analysts.

Current levels places Jaguar Health, Inc. Over the past month the firm's stock is 10.26%, -48.10% for the last quarter, -72.39% for the past six-months and -78.93% for the previous year.

Previously Jaguar Animal Cmn (NASDAQ:JAGX) reported $-0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $-0.22 by $0.1.

Digging a bit further, company shares have been noted -86.13% off the 52 week high and 102.10% away from the 52 week low.

Jaguar Animal Cmn (NASDAQ:JAGX)'s trailing twelve month revenues are $1.8 Million, whereas its price to sales ratio for the same period is 8. Accern also assigned media coverage about the biotechnology company an impact score of 45.8490040592719 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE